Position in MRNA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$121,548,804
+$77,266,001 QoQ
Shares Held
2,392,693
+59.3% QoQ
Ownership
0.603%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. MRNA ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,855 | $267,994,047 | |
| 2 | INCY |
Incyte Corp
|
1,500,792 | $141,254,543 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306,461 | $136,847,094 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
382,701 | $126,624,279 | |
| 5 | MRNA |
Moderna, Inc.
This page
|
2,392,693 | $121,548,804 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,534,992 | $108,725,806 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
577,479 | $97,605,500 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,482,340 | $95,803,634 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $121,548,804 | 2,392,693 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $44,282,803 | 1,501,621 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $26,670,301 | 1,032,532 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $34,017,145 | 1,232,952 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $25,933,701 | 914,769 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $27,794,857 | 668,467 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $42,558,814 | 636,822 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $60,423,800 | 508,832 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $64,399,109 | 604,346 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $88,840,276 | 893,316 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $81,709,103 | 791,065 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $91,277,847 | 751,258 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $102,711,539 | 668,782 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $143,640,497 | 799,691 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $74,138,020 | 626,960 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $72,112,679 | 504,814 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $87,382,846 | 507,273 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $92,696,604 | 364,976 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $184,535,366 | 479,487 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $179,065,099 | 762,044 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $70,055,761 | 534,981 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $42,016,058 | 402,183 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $25,591,336 | 361,715 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $25,872,392 | 402,934 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $13,146,432 | 438,946 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||